Related references
Note: Only part of the references are listed.Antitumor effects of HSV-TK-engineered donor lymphocytes after allogeneic stem-cell transplantation
Fabio Ciceri et al.
BLOOD (2007)
Redirecting T lymphocyte specificity by T cell receptor gene transfer - A new era for immunotherapy
Boris Engels et al.
MOLECULAR ASPECTS OF MEDICINE (2007)
Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex
Mirjam H. M. Heemskerk et al.
BLOOD (2007)
Designer T cells by T cell receptor replacement
Daniel Sommermeyer et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
Complement-induced cell death by rituximab depends on CD20 expression level and acts complementary to antibody-dependent cellular cytotoxicity
Tom van Meerten et al.
CLINICAL CANCER RESEARCH (2006)
Adoptive T-cell transfer in cancer immunotherapy
Siok-Keen Tey et al.
IMMUNOLOGY AND CELL BIOLOGY (2006)
Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation
C Berger et al.
BLOOD (2006)
An inducible caspase 9 safety switch for T-cell therapy
KC Straathof et al.
BLOOD (2005)
A listing of human tumor antigens recognized by T cells: March 2004 update
L Novellino et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Exploiting T cell receptor genes for cancer immunotherapy
S Xue et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
Monoclonal antibody therapy of cancer
GP Adams et al.
NATURE BIOTECHNOLOGY (2005)
Diabetes incidence is unaltered in glutamate decarboxylase 65-specific TCR retrogenic Nonobese diabetic mice: Generation by retroviral-mediated stem cell gene transfer
PY Arnold et al.
JOURNAL OF IMMUNOLOGY (2004)
Prolonged culture of vaccine-primed lymphocytes results in decreased antitumor killing and change in cytokine secretion
JJ Sussman et al.
CANCER RESEARCH (2004)
Cancer immunotherapy: A treatment for the masses
JN Blattman et al.
SCIENCE (2004)
Tumor cells escape suicide gene therapy by genetic and epigenetic instability
O Frank et al.
BLOOD (2004)
Dual T cell receptor T cells with two defined specificities mediate tumor suppression via both receptors
M Gladow et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Characterization of CD20-transduced T lymphocytes as an alternative suicide gene therapy approach for the treatment of graft-versus-host disease
M Serafini et al.
HUMAN GENE THERAPY (2004)
Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region
MHM Heemskerk et al.
BLOOD (2003)
High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens
RA Morgan et al.
JOURNAL OF IMMUNOLOGY (2003)
Adoptive-cell-transfer therapy for the treatment of patients with cancer
ME Dudley et al.
NATURE REVIEWS CANCER (2003)
Retroviral vectors for high-level transgene expression in T lymphocytes
B Engels et al.
HUMAN GENE THERAPY (2003)
Kinetics of cell death in T lymphocytes genetically modified with two novel suicide fusion genes
K Junker et al.
GENE THERAPY (2003)
Cutting edge:: CD8+ effector T cells reject tumors by direct antigen recognition but indirect action on host cells
T Schüler et al.
JOURNAL OF IMMUNOLOGY (2003)
Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertional mutagenesis
NB Woods et al.
BLOOD (2003)
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
ME Dudley et al.
SCIENCE (2002)
Improving the efficacy of antibody-based cancer therapies
P Carter
NATURE REVIEWS CANCER (2001)
A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease
DC Thomis et al.
BLOOD (2001)
Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft
P Tiberghien et al.
BLOOD (2001)
Melanocyte destruction after antigen-specific immunotherapy of melanoma: Direct evidence of T cell-mediated vitiligo
C Yee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1
J Stitz et al.
VIROLOGY (2000)
Plat-E: an efficient and stable system for transient packaging of retroviruses
S Morita et al.
GENE THERAPY (2000)
Genetic modification of human T cells with CD20: A strategy to purify and lyse transduced cells with anti-CD20 antibodies
M Introna et al.
HUMAN GENE THERAPY (2000)
Share Paper
